药物建议,以优化MDR/RR-TB治疗结果,基于多中心,大规模,中国的回顾性队列研究

Lin Fan1, Ming Yang2, Yu-Tong Han3,4

  • 1Department of Tuberculosis, Shanghai Clinical Research Center for Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai Clinical Research Center for Tuberculosis, Shanghai Key Lab of Tuberculosis, Shanghai, China.

概括

这项研究建议Bedaquiline,Linezolid和Cycloserin用于治疗多药耐药结核病 (MDR/RR-TB). 由于不良结果的增加,不建议注射Capreomycin等药物.